4-Pentenylboronic acid
Product Information
Molecular Formula
C5H11BO2
Molecular Weight
114.0
Description
4-Pentenylboronic acid is a versatile compound widely used in biomedicine. It acts as a reactive intermediate in the synthesis of various drugs, such as antineoplastic agents for treating cancer. Additionally, it plays a crucial role in the development of treatments for inflammatory diseases, including rheumatoid arthritis and Crohn's disease. With its unique chemical properties, 4-Pentenylboronic acid holds great promise in advancing pharmaceutical research and drug discovery.
Synonyms
PENT-4-EN-1-YLBORONIC ACID; Pent-4-enylboronic Acid; (pent-4-en-1-yl)boronic acid; 4-Pentenylboronic acid, >=95%; PENT-4-EN-1-YLBORONICACID
IUPAC Name
pent-4-enylboronic acid
SMILES
B(CCCC=C)(O)O
InChI
InChI=1S/C5H11BO2/c1-2-3-4-5-6(7)8/h2,7-8H,1,3-5H2
InChI Key
OYPOYNGGXOZFOZ-UHFFFAOYSA-N
Melting Point
129-143 °C
Flash Point
Not applicable
Purity
95%
Appearance
White to yellow solid
Storage
2-8°C
Safety Information
Hazards
H319
Precautionary Statement
P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
4
Exact Mass
114.0852098 g/mol
Monoisotopic Mass
114.0852098 g/mol
Topological Polar Surface Area
40.5Ų
Heavy Atom Count
8
Formal Charge
0
Complexity
63.4
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113797383-A | High-elasticity high-drug-loading-rate embolism microsphere and preparation method thereof | 2021-09-28 |
| JP-2022021687-A | Method for Producing N-Substituted (Meta) Acrylamide | 2020-07-22 |
| CA-3054300-A1 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| EP-3585824-A2 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| US-2020062877-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | 2017-02-22 |
| WO-2018156766-A2 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| WO-2017206671-A1 | Dynamic polymer with dynamic cross-linked structure | 2016-06-01 |
| AU-2016286200-A1 | Polycyclic amide derivatives as CDK9 inhibitors | 2015-06-29 |
| AU-2016286200-B2 | Polycyclic amide derivatives as CDK9 inhibitors | 2015-06-29 |
| CA-2989499-A1 | Polycyclic amide derivatives as cdk9 inhibitors | 2015-06-29 |
